Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression
Authors
Keywords
-
Journal
World Journal of Stem Cells
Volume 15, Issue 8, Pages 787-806
Publisher
Baishideng Publishing Group Inc.
Online
2023-08-25
DOI
10.4252/wjsc.v15.i8.787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross talk between glucose metabolism and immunosuppression in IFN-γ–primed mesenchymal stem cells
- (2022) Mengwei Yao et al. Life Science Alliance
- Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton’s Jelly
- (2021) Sungho Shin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heterospheroid formation improves therapeutic efficacy of mesenchymal stem cells in murine colitis through immunomodulation and epithelial regeneration
- (2021) Shobha Regmi et al. BIOMATERIALS
- Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway
- (2021) Yuki Nakamori et al. Frontiers in Immunology
- WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
- (2021) Meizhang Li et al. Journal of Extracellular Vesicles
- PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis
- (2021) Thais G. Moreira et al. Nature Communications
- Mesenchymal Stem Cell‐Derived Extracellular Vesicles with High PD‐L1 Expression for Autoimmune Diseases Treatment
- (2021) Fang Xu et al. ADVANCED MATERIALS
- Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients
- (2021) Mairvat Al- Mrahleh et al. Frontiers in Immunology
- Pathogenic Activation of Mesenchymal Stem Cells is induced by the Disease Microenvironment in Systemic Sclerosis
- (2020) Zeinab Taki et al. Arthritis & Rheumatology
- Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-γ treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis
- (2020) Xiao He et al. ANNALS OF THE RHEUMATIC DISEASES
- Regenerative potential of Wharton's jelly‐derived mesenchymal stem cells: A new horizon of stem cell therapy
- (2020) Hossein Abbaszadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immunosuppressive Property of MSCs Mediated by Cell Surface Receptors
- (2020) Siyu Liu et al. Frontiers in Immunology
- The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
- (2020) Katie Hudson et al. Frontiers in Immunology
- Ulcerative colitis
- (2020) Taku Kobayashi et al. Nature Reviews Disease Primers
- Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis
- (2020) Janine Bilsborough et al. Expert Opinion on Drug Discovery
- Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead
- (2019) Amandda Évelin Silva- Carvalho et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
- (2019) Xiang Ao et al. JOURNAL OF IMMUNOTHERAPY
- Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells
- (2019) L.L. Liau et al. Current Research in Translational Medicine
- Mechanisms Controlling PD-L1 Expression in Cancer
- (2019) Jong-Ho Cha et al. MOLECULAR CELL
- PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice
- (2018) Ke Ni et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells
- (2018) Qingdong Guan et al. CYTOTHERAPY
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis
- (2018) Yi Yang et al. Journal of Translational Medicine
- B7‑H1‑mediated immunosuppressive properties in human mesenchymal stem cells are mediated by STAT‑1 and not PI3K/Akt signaling
- (2018) In Jang et al. Molecular Medicine Reports
- Expression of Programmed Death-Ligand 1 by Human Colonic CD90+ Stromal Cells Differs Between Ulcerative Colitis and Crohn’s Disease and Determines Their Capacity to Suppress Th1 Cells
- (2018) Ellen J. Beswick et al. Frontiers in Immunology
- Bioactive factors secreted from mesenchymal stromal cells protect the intestines from experimental colitis in a three-dimensional culture
- (2018) FABIANY DA COSTA GONÇALVES et al. CYTOTHERAPY
- IL-27 regulates the adherence, proliferation, and migration of MSCs and enhances their regulatory effects on Th1 and Th2 subset generations
- (2017) Fenghuang Xu et al. IMMUNOLOGIC RESEARCH
- Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway
- (2017) Ji-Yon Kim et al. Journal of Tissue Engineering and Regenerative Medicine
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis
- (2016) Jianxia Hu et al. Experimental and Therapeutic Medicine
- Culture medium from TNF-α–stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms
- (2015) Wenru Su et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
- (2015) Wei-Bei Wang et al. Stem Cell Reports
- Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
- (2015) Roberto Bellucci et al. OncoImmunology
- The PD-1/PD-Ls pathway and autoimmune diseases
- (2014) Suya Dai et al. CELLULAR IMMUNOLOGY
- Protective effects of Fc-fused PD-L1 on two different animal models of colitis
- (2014) Mi-Young Song et al. GUT
- Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation
- (2014) Dagmar Quandt et al. Journal of Translational Medicine
- Regulation of NF-κB by TNF family cytokines
- (2014) Matthew S. Hayden et al. SEMINARS IN IMMUNOLOGY
- Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells
- (2014) Feng-Juan Lv et al. STEM CELLS
- Human Umbilical Cord Blood Mesenchymal Stem Cells Reduce Colitis in Mice by Activating NOD2 Signaling to COX2
- (2013) Hyung–Sik Kim et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search